FDA start proefproject voor beveiligen import van medicijnen

A US FDA pilot project aimed at enhancing the security of imported medicines has got underway. The programme should allow the agency to focus its surveillance efforts on high-risk shipments that are most likely to be adulterated or counterfeit, whilst cutting red tape and delays for low-risk imports.
Up to 40% of the drugs Americans take are manufactured outside US borders, while 80% of the active pharmaceutical ingredients come from foreign sources. It is widely recognised that the FDA will never have the capacity to screen all imported drug shipments so the new risk-based approach should help it direct resources most effectively (Website Securing Industry, 20 februari 2014).
Klik hier voor het volledige artikel.

Dit bericht is ook opgenomen in ons maandelijkse overzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.